MEDIORG

Medicamen Organics Share Price

 
Stock Hit Upper Circuit

 

Start SIP in MEDIORG

Start SIP
Medicamen Organics live price: ₹23.25. It opened at ₹23 vs previous close ₹22; intraday high/low: ₹23/₹23. The 50 & 200 DMA stand at ₹23.83/₹32.42.

Medicamen Organics Performance

  • Today's Low
  • ₹23
  • Today's High
  • ₹23
  • 52 Week Low
  • ₹20
  • 52 Week High
  • ₹50
  • Open Price₹23
  • Previous Close₹22
  • Volume8,000
  • 50 DMA₹23.83
  • 100 DMA₹26.30
  • 200 DMA₹32.42

Investment Returns

  • Over 1 Month + 1.97%
  • Over 3 Month -12.1%
  • Over 6 Month -30.08%
  • Over 1 Year -1.06%

Smart Investing Starts Here Start SIP with Medicamen Organics for Steady Growth!

Invest Now

Medicamen Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 28
  • P/B Ratio
  • 0.9
  • Average True Range
  • 1.34
  • EPS
  • 3.46
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.72
  • RSI
  • 51.99
  • MFI
  • 57.07

Medicamen Organics Financials

Medicamen Organics Technicals

EMA & SMA

Current Price
₹23.25
+ 1.1 (4.97%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹22.51
  • 50 Day
  • ₹23.83
  • 100 Day
  • ₹26.30
  • 200 Day
  • ₹32.42

Resistance and Support

23.25 Pivot Speed
  • R3 23.25
  • R2 23.25
  • R1 23.25
  • S1 23.25
  • S2 23.25
  • S3 23.25

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medicamen Organics Ltd has an operating revenue of Rs. 81.31 Cr. on a trailing 12-month basis. An annual revenue growth of 51% is outstanding, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medicamen Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-03-13 To consider Fund Raising
2025-11-14 Quarterly Results
2025-05-29 Audited Results
2025-01-08 To consider Fund Raising
2024-11-14 Quarterly Results & Others To consider other business matters.

Medicamen Organics F&O

Medicamen Organics Shareholding Pattern

61.27%
0%
0.07%
28.75%
9.91%

Medicamen Organics FAQs

Medicamen Organics share price is ₹23 As on 03 April, 2026 | 12:19

The Market Cap of Medicamen Organics is ₹28.3 Cr As on 03 April, 2026 | 12:19

The P/E ratio of Medicamen Organics is 7 As on 03 April, 2026 | 12:19

The PB ratio of Medicamen Organics is 0.9 As on 03 April, 2026 | 12:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23